Sign up to save your podcasts
Or
Share S4 | E6 | AI in Drug Discovery with Josh Haimson - Inductive Bio
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
S4 | E6 | AI in Drug Discovery with Josh Haimson - Inductive Bio
AI is everywhere in biotech, but where does it genuinely create impact?
In this episode of the ThinkData Podcast, I sat down with Josh Haimson, Co-Founder and CEO of Inductive Bio, to explore how AI-driven virtual chemistry labs are transforming drug discovery.
We cover:
- Where AI truly outperforms traditional approaches in drug development
- Why computational models are finally earning real trust from scientists
- What Inductive Bio’s Series A unlocked, and how they’re balancing speed vs depth
- The role of industry partnerships and early adopters in shaping the platform
- Where are the biggest AI opportunities in drug discovery over the next 3–5 years
A grounded, technical, and refreshingly honest conversation about the future of AI-powered therapeutics.
View all episodes
By Dataworks Group LimitedAI is everywhere in biotech, but where does it genuinely create impact?
In this episode of the ThinkData Podcast, I sat down with Josh Haimson, Co-Founder and CEO of Inductive Bio, to explore how AI-driven virtual chemistry labs are transforming drug discovery.
We cover:
- Where AI truly outperforms traditional approaches in drug development
- Why computational models are finally earning real trust from scientists
- What Inductive Bio’s Series A unlocked, and how they’re balancing speed vs depth
- The role of industry partnerships and early adopters in shaping the platform
- Where are the biggest AI opportunities in drug discovery over the next 3–5 years
A grounded, technical, and refreshingly honest conversation about the future of AI-powered therapeutics.